Liver-in-Cube

"Liver-in-Cube”- the world's first 3D-bioprinted biomimetic liver cancer precision theranostic platform, precisely reconstructs the liver cancer microenvironment using patient-derived cells and extracellular matrix. The platform creates personalized “patient avatars” for drug screening that significantly improves the prediction accuracy of drug response rate. This platform overcomes the limitations of empirical animal model and organoid by providing a highly biomimetic, standardized, and high-throughput solution for drug efficacy and pharmacokinetic assessment, shortening R&D cycles and increasing clinical trial success rates. The technology is expanding into a comprehensive precision oncology theranostic system, poised to become the gold standard in cancer standard of care and establish a new paradigm in precision cancer therapy.